全文获取类型
收费全文 | 622篇 |
免费 | 66篇 |
国内免费 | 1篇 |
出版年
2024年 | 2篇 |
2023年 | 6篇 |
2022年 | 7篇 |
2021年 | 19篇 |
2020年 | 14篇 |
2019年 | 12篇 |
2018年 | 24篇 |
2017年 | 20篇 |
2016年 | 30篇 |
2015年 | 37篇 |
2014年 | 43篇 |
2013年 | 44篇 |
2012年 | 37篇 |
2011年 | 42篇 |
2010年 | 17篇 |
2009年 | 21篇 |
2008年 | 43篇 |
2007年 | 25篇 |
2006年 | 27篇 |
2005年 | 25篇 |
2004年 | 24篇 |
2003年 | 10篇 |
2002年 | 16篇 |
2001年 | 15篇 |
2000年 | 14篇 |
1999年 | 13篇 |
1998年 | 11篇 |
1997年 | 7篇 |
1996年 | 9篇 |
1994年 | 4篇 |
1993年 | 9篇 |
1992年 | 6篇 |
1991年 | 4篇 |
1990年 | 3篇 |
1989年 | 3篇 |
1987年 | 3篇 |
1986年 | 3篇 |
1985年 | 2篇 |
1984年 | 6篇 |
1983年 | 3篇 |
1981年 | 4篇 |
1979年 | 2篇 |
1978年 | 3篇 |
1975年 | 2篇 |
1972年 | 1篇 |
1971年 | 6篇 |
1970年 | 1篇 |
1969年 | 2篇 |
1968年 | 3篇 |
1966年 | 1篇 |
排序方式: 共有689条查询结果,搜索用时 15 毫秒
101.
A. Aires V.R. Mota M.J. Saavedra E.A.S. Rosa R.N. Bennett 《Journal of applied microbiology》2009,106(6):2086-2095
Aims: The aim of the study was to evaluate the in vitro antibacterial activity of glucosinolates and their enzymatic hydrolysis product against bacteria isolated from the human intestinal tract.
Methods and results: Using a disc diffusion bioassay, different doses of intact glucosinolates and their corresponding hydrolysis products were tested. There were clear structure–activity and concentration differences with respect to the in vitro growth inhibition effects as well as differences in the sensitivities of the individual bacteria. The most effective glucosinolate hydrolysis products were the isothiocyanates; sulforaphane and benzyl isothiocyanate were the best inhibitors of growth. Indole-3-carbinol had some inhibitory effects against the Gram-positive bacteria but had no effect, even at the highest dose, against the Gram-negative bacteria. Indole-3-acetonitrile had some inhibitory activity against the Gram-negative bacteria. Glucosinolates, nitriles and amines were ineffective at all the doses used.
Conclusions: Glucosinolate hydrolysis products and specifically the isothiocyanates SFN and BITC have significant antimicrobial activity against Gram-positive and Gram-negative bacteria, and might be useful in controlling human pathogens through the diet.
Significance and Impact of the Study: This the first major in vitro study demonstrating the potential of these natural dietary chemicals as an alternative to, or in combination with, current antibiotic-based therapies for treating infectious diseases. 相似文献
Methods and results: Using a disc diffusion bioassay, different doses of intact glucosinolates and their corresponding hydrolysis products were tested. There were clear structure–activity and concentration differences with respect to the in vitro growth inhibition effects as well as differences in the sensitivities of the individual bacteria. The most effective glucosinolate hydrolysis products were the isothiocyanates; sulforaphane and benzyl isothiocyanate were the best inhibitors of growth. Indole-3-carbinol had some inhibitory effects against the Gram-positive bacteria but had no effect, even at the highest dose, against the Gram-negative bacteria. Indole-3-acetonitrile had some inhibitory activity against the Gram-negative bacteria. Glucosinolates, nitriles and amines were ineffective at all the doses used.
Conclusions: Glucosinolate hydrolysis products and specifically the isothiocyanates SFN and BITC have significant antimicrobial activity against Gram-positive and Gram-negative bacteria, and might be useful in controlling human pathogens through the diet.
Significance and Impact of the Study: This the first major in vitro study demonstrating the potential of these natural dietary chemicals as an alternative to, or in combination with, current antibiotic-based therapies for treating infectious diseases. 相似文献
102.
We demonstrated that the infection of humanized NOD-scid IL2rγ null mice with different strains (representing the four genotypes) of dengue virus serotype 2 (DEN-2) can induce the development of human-like disease, including fever, viremia, erythema, and thrombocytopenia. Newborn mice were irradiated and received transplants by intrahepatic inoculation of human cord blood-derived hematopoietic progenitor cells (CD34+). After 6 weeks, mouse peripheral blood was tested by flow cytometry to determine levels of human lymphocytes (CD45+ cells); rates of reconstitution ranged from 16 to 80% (median, 52%). Infection (with approximately 106 PFU, the equivalent of a mosquito bite) of these humanized mice with eight low-passage-number strains produced a high viremia extending to days 12 to 18 postinfection. We observed a significant decrease in platelets at day 10 in most of the mice and an increase in body temperature (fever) and erythema (rash) in comparison with humanized mice inoculated with cell culture medium only. Comparison of Southeast (SE) Asian and other genotype viruses (American, Indian, and West African) in this model showed significant differences in magnitude and duration of viremia and rash, with the SE Asian viruses always being highest. Indian genotype viruses produced lower viremias and less thrombocytopenia than the others, and West African (sylvatic) viruses produced the shortest periods of viremia and the lowest rash measurements. These results correlate with virulence and transmission differences described previously for primary human target cells and whole mosquitoes and may correlate with epidemiologic observations around the world. These characteristics make this mouse model ideal for the study of dengue pathogenesis and the evaluation of vaccine attenuation and antivirals.Dengue viruses, which cause the disease dengue fever (DF) and its more severe form, dengue hemorrhagic fever (DHF), in humans, have been spreading to more areas of the world along with their mosquito (Aedes aegypti and Aedes albopictus) vectors. Now over 100 countries are affected, including some areas of the United States (Texas and Hawaii) (5, 26). Due to the fact that only humans show clinical signs and symptoms of disease, it has been difficult to directly test the mechanisms of pathogenesis of these viruses (4). Through decades of research, including clinical, epidemiologic, and laboratory studies, the factors involved in producing disease, whether it be DF or DHF, have remained unproved. However, there are many indications that both the virus and the host contribute to the occurrence and severity of disease: there are genetic differences in the virus and host immune response that can be measured in vitro, and these factors seem to lead to immunopathology in addition to the damage done by virus replication. Because there are four antigenically distinct dengue viruses (serotypes 1 to 4), humans can theoretically have dengue virus infections leading to clinical disease up to four times, and the immunity to the first virus enhances the probability of developing severe dengue after a subsequent infection. Thus, the development of vaccines has been hampered by the unknown effects of inoculating with a tetravalent preparation that might cause immunopathology or severe disease, and there are no appropriate animal models in which to test vaccine attenuation and efficacy for human applications.In 2005 we reported the development of humanized NOD/SCID (nonobese diabetic/severe combined immunodeficient) mice that produced signs of DF upon infection with one strain of dengue virus (3). The mice were humanized by giving them transplants of purified hematopoietic stem cells from human umbilical cord blood (CB) samples taken from normal births. After subcutaneous infection with a low dose of a Southeast (SE) Asian virus, the viremia, rash, and thrombocytopenia were significantly higher, longer lasting, and more like human disease than in any other animal model described at the time. We concluded that this model could be used to test antiviral treatments, since these mice did not produce measurable human antibodies. Since then, many other immunodeficient mouse strains have been produced that can have enhanced human engraftment levels, and they develop functional human immune system cells, including some level of adaptive immunity (20). It has been reported that some of these mouse strains develop immunoglobulins specific for human immunodeficiency virus and dengue virus, albeit at low levels (14, 25).Here we present results of dengue virus pathogenesis studies in a new mouse strain, NOD-scid IL2rγ null, that has a much higher degree of human lymphocyte development (median of 52%, versus 14% previously). The comparison of viruses from different genetic subgroups of dengue serotype 2 has led us to conclude that this model is reflective of actual human dengue pathogenesis, and this development might bring us to a new era in testing the factors that contribute to dengue disease. 相似文献
103.
Luís Jaime Mota Amy E. Ramsden Mei Liu J. David Castle David W. Holden 《Cellular microbiology》2009,11(8):1236-1253
Salmonella enterica are facultative intracellular bacterial pathogens that proliferate within host cells in a membrane-bounded compartment, the Salmonella -containing vacuole (SCV). Intracellular replication of Salmonella is mediated by bacterial effectors translocated on to the cytoplasmic face of the SCV membrane by a type III secretion system. Some of these effectors manipulate the host endocytic pathway, resulting in the formation in epithelial cells of tubules enriched in late endosomal markers, known as Salmonella -induced filaments (SIFs). However, much less is known about possible interference of Salmonella with the secretory pathway. Here, a small-interference RNA screen revealed that secretory carrier membrane proteins (SCAMPs) 2 and 3 contribute to the maintenance of SCVs in the Golgi region of HeLa cells. This is likely to reflect a function of SCAMPs in vacuolar membrane dynamics. Moreover, SCAMP3, which accumulates on the trans -Golgi network in uninfected cells, marked tubules induced by Salmonella effectors that overlapped with SIFs but which also comprised distinct tubules lacking late endosomal proteins. We propose that SCAMP3 tubules reflect a manipulation of specific post-Golgi trafficking that might allow Salmonella to acquire nutrients and membrane, or to control host immune responses. 相似文献
104.
105.
J?natas S. Abrah?o Maria Isabel M. Guedes Giliane S. Trindade Flávio G. Fonseca Rafael K. Campos Bruno F. Mota Zélia I. P. Lobato André T. Silva-Fernandes Gisele O. L. Rodrigues Larissa S. Lima Paulo C. P. Ferreira Cláudio A. Bonjardim Erna G. Kroon 《PloS one》2009,4(10)
Background
Despite the fact that smallpox eradication was declared by the World Health Organization (WHO) in 1980, other poxviruses have emerged and re-emerged, with significant public health and economic impacts. Vaccinia virus (VACV), a poxvirus used during the WHO smallpox vaccination campaign, has been involved in zoonotic infections in Brazilian rural areas (Bovine Vaccinia outbreaks – BV), affecting dairy cattle and milkers. Little is known about VACV''s natural hosts and its epidemiological and ecological characteristics. Although VACV was isolated and/or serologically detected in Brazilian wild animals, the link between wildlife and farms has not yet been elucidated.Methodology/Principal Findings
In this study, we describe for the first time, to our knowledge, the isolation of a VACV (Mariana virus - MARV) from a mouse during a BV outbreak. Genetic data, in association with biological assays, showed that this isolate was the same etiological agent causing exanthematic lesions observed in the cattle and human inhabitants of a particular BV-affected area. Phylogenetic analysis grouped MARV with other VACV isolated during BV outbreaks.Conclusion/Significance
These data provide new biological and epidemiological information on VACV and lead to an interesting question: could peridomestic rodents be the link between wildlife and BV outbreaks? 相似文献106.
Ivo H. J. Ploemen Miguel Prudêncio Bruno G. Douradinha Jai Ramesar Jannik Fonager Geert-Jan van Gemert Adrian J. F. Luty Cornelus C. Hermsen Robert W. Sauerwein Fernanda G. Baptista Maria M. Mota Andrew P. Waters Ivo Que Clemens W. G. M. Lowik Shahid M. Khan Chris J. Janse Blandine M. D. Franke-Fayard 《PloS one》2009,4(11)
The quantitative analysis of Plasmodium development in the liver in laboratory animals in cultured cells is hampered by low parasite infection rates and the complicated methods required to monitor intracellular development. As a consequence, this important phase of the parasite''s life cycle has been poorly studied compared to blood stages, for example in screening anti-malarial drugs. Here we report the use of a transgenic P. berghei parasite, PbGFP-Luccon, expressing the bioluminescent reporter protein luciferase to visualize and quantify parasite development in liver cells both in culture and in live mice using real-time luminescence imaging. The reporter-parasite based quantification in cultured hepatocytes by real-time imaging or using a microplate reader correlates very well with established quantitative RT-PCR methods. For the first time the liver stage of Plasmodium is visualized in whole bodies of live mice and we were able to discriminate as few as 1–5 infected hepatocytes per liver in mice using 2D-imaging and to identify individual infected hepatocytes by 3D-imaging. The analysis of liver infections by whole body imaging shows a good correlation with quantitative RT-PCR analysis of extracted livers. The luminescence-based analysis of the effects of various drugs on in vitro hepatocyte infection shows that this method can effectively be used for in vitro screening of compounds targeting Plasmodium liver stages. Furthermore, by analysing the effect of primaquine and tafenoquine in vivo we demonstrate the applicability of real time imaging to assess parasite drug sensitivity in the liver. The simplicity and speed of quantitative analysis of liver-stage development by real-time imaging compared to the PCR methodologies, as well as the possibility to analyse liver development in live mice without surgery, opens up new possibilities for research on Plasmodium liver infections and for validating the effect of drugs and vaccines on the liver stage of Plasmodium. 相似文献
107.
Laura Azeredo Miranda Mota Jo?o Roberto Neto Ver?nica Gomes Monteiro Caroliny Samary Silva Lobato Marco Antonio de Oliveira Maura da Cunha Heloisa D’ávila Sérgio Henrique Seabra Patrícia Torres Bozza Renato Augusto DaMatta 《Memórias do Instituto Oswaldo Cruz》2014,109(6):767-774
Lipid bodies [lipid droplets (LBs)] are lipid-rich organelles involved in lipid
metabolism, signalling and inflammation. Recent findings suggest a role for LBs in
host response to infection; however, the potential functions of this organelle
in Toxoplasma gondii infection and how it alters macrophage
microbicidal capacity during infection are not well understood. Here, we investigated
the role of host LBs in T. gondii infection in mouse peritoneal
macrophages in vitro. Macrophages cultured with mouse serum (MS) had higher numbers
of LBs than those cultured in foetal bovine serum and can function as a model to
study the role of LBs during intracellular pathogen infection. LBs were found in
association with the parasitophorous vacuole, suggesting that T. gondii
may benefit from this lipid source. Moreover, increased numbers of
macrophage LBs correlated with high prostaglandin E2 (PGE2) production and decreased
nitric oxide (NO) synthesis. Accordingly, LB-enriched macrophages cultured with MS
were less efficient at controlling T. gondii growth. Treatment of
macrophages cultured with MS with indomethacin, an inhibitor of PGE2 production,
increased the microbicidal capacity against T. gondii. Collectively,
these results suggest that culture with MS caused a decrease in microbicidal activity
of macrophages against T. gondii by increasing PGE2 while lowering
NO production. 相似文献
108.
Tainá CC Monte Rosana Gentile Juberlan Garcia Ester Mota Jeannie N Santos Arnaldo Maldonado Júnior 《Memórias do Instituto Oswaldo Cruz》2014,109(8):1057-1063
Angiostrongylus cantonensis is the etiologic agent of eosinophilic
meningoencephalitis in humans. Cases have been recorded in many parts of the world,
including Brazil. The aim of this study was to compare the differences in the biology
and morphology of two different Brazilian haplotypes of A. : ac8 and
ac9. A significantly larger number of L1 larvae eliminated in the faeces of rodents
at the beginning of the patent period was observed for ac9 haplotype and compared to
the total of L1 larvae eliminated, there was a significant difference between the two
haplotypes. The ac9 haplotype showed a significant difference in the proportion of
female and male specimens (0.6:1), but the same was not observed for ac8 (1.2:1). The
morphometric analysis showed that male and female specimens isolated from ac8
haplotype were significantly larger with respect to body length, oesophagus length,
spicule length (male) and distance from the anus to the rear end (female) compared to
specimens from ac9. The morphological analysis by light microscopy showed little
variation in the level of bifurcations at the lateral rays in the right lobe of the
copulatory bursa between the two haplotypes. The biological, morphological and
morphometric variations observed between the two haplotypes agree with the observed
variation at the molecular level using the cytochrome oxidase subunit I marker and
reinforce the possible influence of geographical isolation on the development of
these haplotypes. 相似文献
109.
Luciano Pamplona de Góes Cavalcanti Lia Alves Martins Mota Gustavo Porto Lustosa Mayara Carvalho Fortes Davi Alves Martins Mota Ant?nio Afonso Bezerra Lima Ivo Castelo Branco Coelho Maria Paula Gomes Mour?o 《Memórias do Instituto Oswaldo Cruz》2014,109(1):93-98
In 2009, the World Health Organization (WHO) issued a new guideline that stratifies
dengue-affected patients into severe (SD) and non-severe dengue (NSD) (with or
without warning signs). To evaluate the new recommendations, we completed a
retrospective cross-sectional study of the dengue haemorrhagic fever (DHF) cases
reported during an outbreak in 2011 in northeastern Brazil. We investigated 84
suspected DHF patients, including 45 (53.6%) males and 39 (46.4%) females. The ages
of the patients ranged from five-83 years and the median age was 29. According to the
DHF/dengue shock syndrome classification, 53 (63.1%) patients were classified as
having dengue fever and 31 (36.9%) as having DHF. According to the 2009 WHO
classification, 32 (38.1%) patients were grouped as having NSD [4 (4.8%) without
warning signs and 28 (33.3%) with warning signs] and 52 (61.9%) as having SD. A
better performance of the revised classification in the detection of severe clinical
manifestations allows for an improved detection of patients with SD and may reduce
deaths. The revised classification will not only facilitate effective screening and
patient management, but will also enable the collection of standardised surveillance
data for future epidemiological and clinical studies. 相似文献
110.
de Oliveira C Iwanaga-Carvalho C Mota JF Oyama LM Ribeiro EB Oller do Nascimento CM 《Steroids》2011,76(12):1260-1267